Atrial Fibrillation (AF)

Association Between Early Recurrence and Long-Term Recurrence After Pulsed Field Ablation for Atrial Fibrillation: Prospective Real-World Evidence From China

Alcohol as a Modifiable Risk Factor for Atrial Fibrillation

OPTION-EMEA Clinical Trial

FARAPULSE Workflow Assessment Registry

Validity and Algorithm Development for Detection of Supraventricular Tachycardia in Children-A Clinical Pilot Study

Remote ECG Monitoring Post TAVI

Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

PREACTIVE: Preconditioning Exercise Intervention to Improve Symptoms and Quality of Life in Comorbid Atrial Fibrillation and HFpEF

Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)

P-wave Duration and Local Potential as Predictors of AF Recurrence Following Pulmonary Vein Isolation

Acupuncture for Preventing Atrial Arrhythmia Recurrence After Ablation

Assessment of Medication Adherence in Ccu Admitted Patients

A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation

Burden-Evaluated Atrial Fibrillation Progession and ThromboEmbolim Study BEAT-AF TE Study

FENOX Trial (Comparative Effectiveness of Fexuprazan Co-therapy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants)

Systematic Workflow for Pentaspline Pulsed-field Ablation Optimization